Asia · General news · China Daily
China's innovative therapies lead new cancer battle
Until satri-cel's arrival, commercial CAR T-cell products had been restricted to treating blood cancers. Conquering solid tumors, which make up most human cancers, marks a…
Read the full article on China Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (global.chinadaily.com.cn)



